Top 8 alternative sites to discovertrk.com
3billion | Genetic test for rare disease patients
Patients with rare genetic disease undergo long odyssey to receive a diagnosis. Visit 3billion and find how to order our rare disease genetic testing.
GOCOVRI® (amantadine) extended release capsules
GOCOVRI® (amantadine) helps treat dyskinesia in patients receiving levodopa therapy for Parkinson's disease. Learn more about how GOCOVRI can help, hear from real patients, and find out how to get started. See full safety information.
Some websites with similar theme to discovertrk.com include:
XOLAIR® (omalizumab)
Learn about XOLAIR® (omalizumab) for allergic asthma uncontrolled on inhaled corticosteroids, chronic idiopathic urticaria (CIU) and nasal polyps. See full safety & boxed warning.
LUCENTIS®: Wet AMD, DR, DME, mCNV & RVO Treatment Option
Learn about LUCENTIS (ranibizumab injection), a treatment option for wet AMD, diabetic macular edema (DME), diabetic retinopathy (DR), mCNV, & RVO. See full safety for more information.
GET FINANCIAL SUPPORT
Learn about Avastin® (bevacizumab) solution for IV infusion, including benefits, risks, possible side effects, patient support, and options for financial help. See full safety for more information.
Designed to be Simple
Find information about Nutropin AQ® (somatropin) injection, for subcutaneous use HGH Injection therapy, read about Nutropin GPS co-pay card and learn about the Nutropin AQ® regimen. See full safety for more information.
XOLAIR® (Omalizumab) for Allergic Asthma, Nasal Polyps & CIU Treatment
XOLAIR® (omalizumab) is a treatment for nasal polyps, allergic asthma & chronic idiopathic urticaria (CIU). See full prescribing, safety, & Boxed Warning info.
Author: Which condition below are you interested in
Explore phase 3 data for CLL & AML
Select a VENCLEXTA® (venetoclax tablets) indication. VENCLEXTA is an **** therapy for AML, CLL and SLL patients. See full safety for more information.